ENT62
Addressing the Challenges of Changing the Paradigm for the Treatment of Sleep Apnea. When Implantable Devices Become Routine
Sponsored By:
Ticketed Workshop
This session is a part of a ticketed workshop. After registration, you must reserve your spot for this workshop. Space is limited. More Info
Session Speakers
Session Description
Over the last ten years, society has recognized the importance of a good night’s sleep. With this evolved the ability to improve sleep diagnostics as well as sleep monitoring. Technology was developed and evaluated to address the long-existing challenge of patients with moderate to severe sleep apnea who are unable to benefit from the gold-standard CPAP therapy. Hypoglossal nerve stimulation has been evaluated for many years, and in 2014, Inspire therapy was approved by the FDA. Today, over 14,000 patients have received Inspire therapy and the therapy is fully reimbursed in the United States. On-going technology developments will further improve the procedure and cloud-based tools are evolving to manage patients and ensure strong patient outcomes. The paradigm change is informing patients that very good therapy alternatives exist for those patient who cannot benefit from CPAP.
Session Objectives
After attending this activity, attendees will be able to:
1. Understand the basic mechanism of action of hypoglossal nerve stimulation
2. Understand the proper indication for recommending hypoglossal nerve stimulation
3. Describe the current clinical practice for patient unable to benefit from CPAP
4. Outline current advances in sleep testing and how this can streamline patient care
5. Describe the overall patient management process using hypoglossal nerve stimulation and the responsibilities of both the sleep physicians and the ENT surgeons